These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39358447)

  • 1. Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification.
    Kang MK; Song JE; Loomba R; Park SY; Tak WY; Kweon YO; Lee YR; Park JG
    Sci Rep; 2024 Oct; 14(1):22917. PubMed ID: 39358447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification.
    Kang MK; Song J; Loomba R; Park S; Tak W; Kweon Y; Lee Y; Park JG
    Res Sq; 2024 Mar; ():. PubMed ID: 38496485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of overweight/obesity and overweight/obesity-related metabolic dysfunction-associated steatotic liver disease in young adults with coronary artery calcification later in life.
    Wang JJ; Zheng Z; Zhang Y
    Diabetes Obes Metab; 2024 Sep; 26(9):3860-3867. PubMed ID: 38934214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysis.
    De Filippo O; Di Pietro G; Nebiolo M; Ribaldone DG; Gatti M; Bruno F; Gallone G; Armandi A; Birtolo LI; Zullino V; Mennini G; Corradini SG; Mancone M; Bugianesi E; Iannaccone M; De Ferrari GM; D'Ascenzo F
    Eur J Clin Invest; 2024 Sep; 54(9):e14188. PubMed ID: 38396359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.
    Sung KC; Yoo TK; Lee MY; Byrne CD; Zheng MH; Targher G
    Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):482-491. PubMed ID: 36727522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals.
    Chhabra R; O'Keefe JH; Patil H; O'Keefe E; Thompson RC; Ansari S; Kennedy KF; Lee LW; Helzberg JH
    Mayo Clin Proc; 2013 Nov; 88(11):1259-65. PubMed ID: 24138963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians.
    Wu T; Ye J; Mo S; Ye M; Li X; Li Q; Wang W; Zheng Q; Luo K; Zhang Y; Tu S; Che D; Gong R; Chen X; Miu R; Shao C; Sun Y; Zhong B
    J Gastroenterol Hepatol; 2024 Aug; 39(8):1636-1647. PubMed ID: 38695344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.
    Gao J; Li Y; Zhang Y; Zhan X; Tian X; Li J; Wang R; He Y; Wang A; Wu S
    J Am Heart Assoc; 2024 Mar; 13(5):e032604. PubMed ID: 38390843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAFLD predicts cardiovascular disease risk better than MASLD.
    Pan Z; Shiha G; Esmat G; Méndez-Sánchez N; Eslam M
    Liver Int; 2024 Jul; 44(7):1567-1574. PubMed ID: 38641962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients.
    Takayama Y; Yasuda Y; Suzuki S; Shibata Y; Tatami Y; Shibata K; Niwa M; Sawai A; Morimoto R; Kato S; Ishii H; Maruyama S; Murohara T
    Heart Vessels; 2016 Jul; 31(7):1030-7. PubMed ID: 26164596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort.
    Sung KC; Lim YH; Park S; Kang SM; Park JB; Kim BJ; Shin JH
    Cardiovasc Diabetol; 2013 Nov; 12():162. PubMed ID: 24191863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Walking and Calcified Atherosclerotic Plaque in the Coronary Arteries: The National Heart, Lung, and Blood Institute Family Heart Study.
    Imran TF; Patel Y; Ellison RC; Carr JJ; Arnett DK; Pankow JS; Heiss G; Hunt SC; Gaziano JM; Djoussé L
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1272-7. PubMed ID: 27102966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease.
    Kang MK; Lee YR; Jang SY; Tak WY; Kweon YO; Song JE; Loomba R; Park SY; Park JG
    Hepatol Int; 2023 Jun; 17(3):626-635. PubMed ID: 37069419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Nonalcoholic Hepatic Steatosis on the Warranty Period of a Coronary Artery Calcium Score of 0: Results From the Multi-Ethnic Study of Atherosclerosis.
    Ichikawa K; Lim J; McClelland RL; Susarla S; Krishnan S; Benzing T; Kianoush S; Aldana-Bitar J; Manubolu VS; Budoff MJ
    Circ Cardiovasc Imaging; 2024 Sep; 17(9):e016465. PubMed ID: 39288206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease.
    Nishihara T; Miyoshi T; Nakashima M; Miki T; Toda H; Yoshida M; Ichikawa K; Osawa K; Yuasa S
    Cardiovasc Diabetol; 2024 May; 23(1):167. PubMed ID: 38730426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction.
    Park HJ; Lee S; Lee JS
    Abdom Radiol (NY); 2024 Sep; 49(9):3036-3044. PubMed ID: 38587630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
    Khawaja T; Linge J; Leinhard OD; Al-Kindi SG; Rajagopalan S; Khera A; de Lemos JA; Joshi P; Neeland IJ
    Prog Cardiovasc Dis; 2023; 78():67-73. PubMed ID: 36931545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between carotid atherosclerosis and coronary artery calcification in asymptomatic diabetic patients: A prospective multicenter study.
    Jeevarethinam A; Venuraju S; Dumo A; Ruano S; Mehta VS; Rosenthal M; Nair D; Cohen M; Darko D; Lahiri A; Rakhit R
    Clin Cardiol; 2017 Sep; 40(9):752-758. PubMed ID: 28543093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAFLD identifies patients with significant hepatic fibrosis better than MASLD.
    Pan Z; Al-Busafi SA; Abdulla M; Fouad Y; Sebastiani G; Eslam M
    Hepatol Int; 2024 Jun; 18(3):964-972. PubMed ID: 38717690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery calcification correlates with the presence and severity of valve calcification.
    Koulaouzidis G; Nicoll R; MacArthur T; Jenkins PJ; Henein MY
    Int J Cardiol; 2013 Oct; 168(6):5263-6. PubMed ID: 23993324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.